Barings LLC United Therapeutics Corp Transaction History

Barings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $202,822 - $246,930	-2,590 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $338,467 - $537,604	-4,450 Reduced 63.21%	2,590 $202,000
Q4 2018 Feb 07, 2019	BUY	$101.4 - $128.73 $248,430 - $315,388	2,450 Added 53.38%	7,040 $767,000
Q2 2018 Aug 03, 2018	BUY	$101.14 - $118.31 $216,439 - $253,183	2,140 Added 87.35%	4,590 $519,000
Q4 2017 Feb 08, 2018	SELL	$118.58 - $151.28 $201,586 - $257,176	-1,700 Reduced 40.96%	2,450 $362,000
Q2 2017 Aug 15, 2017	SELL	N/A	-5,520 Reduced 57.08%	4,150 $538,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,670	9,670 $0

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.